Asia-Pacific markets were mostly down Wednesday, with Chinese markets declining as investors digested key Chinese economic data.
Meanwhile, Chinese biotech firm BeiGene made its debut in Shanghai.
In Japan, the Nikkei 225 recovered 27.08 points, or 0.1%, to 28,640.49.
Toyota shares jumped 3.59% after it announced it will invest eight trillion yen ($70 billion U.S.) into electrifying its vehicles by 2030,
The Japanese yen traded at 113.67 per U.S. dollar, as it continued to weaken from levels around 113.5.
In Hong Kong, the Hang Seng dropped 215.19 points, or 0.9%, to 23,420.78.
The Australian dollar rose to $0.7123.
CHINA
In China, the CSI 300 slid 43.8 points, or 0.9%, to 5,005.90.
BeiGene made its debut in Shanghai’s NASDAQ-style board Star Market at an offer price of 192.6 yuan ($30.24 U.S.) per share, after raising over $3 billion. However, the stock opened 8.1% below that offer price, at 176.96 yuan per share. It closed at 160.98 yuan, or about 16% down.
The company is already listed in Hong Kong and the NASDAQ in the U.S.
China released a slew of key economic data on Wednesday. Its industrial output for November was up 3.8% year-on-year, more than the 3.5% increase in October, and better than the 3.6% expected in a Reuters poll.
Data also showed that retail sales in November rose 3.9% year-on-year, less than October’s 4.9% increase, and below the expectations of 4.6% in a Reuters poll.
In other markets
In Taiwan, the Taiex regrouped 60.73 points, or 0.4%, to 17,660.10
In Singapore, the Straits Times Index fell 6.21 points, or 0.2%, to 3,114.88
In Korea, the Kospi index inched forward 1.44 points to 2,989.39
In New Zealand, the NZX 50 shed 60.18 points, or 0.5%, to 12,869.41
In Australia, the ASX 200 deleted 51.3 points, or 0.7%, at 7,327.08
